These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18317648)

  • 21. [Does the criterium of positivity for the immunohistochemical analysis of p53 in the confirmation of Barrett's dysplasia make any difference?].
    Lopes CV; Pereira-Lima JC; Hartmann AA; Tonelotto E; Salgado K
    Arq Gastroenterol; 2005; 42(4):233-8. PubMed ID: 16444378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
    Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
    Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus.
    Dunn LJ; Jankowski JA; Griffin SM
    Dig Dis Sci; 2015 May; 60(5):1187-94. PubMed ID: 25424203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus.
    Li C; Yamashita DT; Hawel JD; Bethune D; Henteleff H; Ellsmere J
    Surg Endosc; 2017 Oct; 31(10):4211-4216. PubMed ID: 28342132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus.
    Rioux-Leclercq N; Turlin B; Sutherland F; Heresbach N; Launois B; Campion JP; Ramee MP
    Oncol Rep; 1999; 6(4):877-82. PubMed ID: 10373674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
    Asthana N; Mandich D; Ligato S
    Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
    Probst A; Aust D; Märkl B; Anthuber M; Messmann H
    Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysplasia in Barrett's esophagus: limitations of current management strategies.
    Spechler SJ
    Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up results of stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia.
    Belghazi K; van Vilsteren FGI; Weusten BLAM; Meijer SL; Bergman JJGHM; Pouw RE
    Gastrointest Endosc; 2018 Jan; 87(1):77-84. PubMed ID: 28455160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer.
    Seewald S; Ang TL; Soehendra N
    Postgrad Med J; 2007 Jun; 83(980):367-72. PubMed ID: 17551066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic transgastric esophageal mucosal resection for high-grade dysplasia.
    Frantzides CT; Madan AK; Moore RE; Zografakis JG; Carlson MA; Keshavarzian A
    J Laparoendosc Adv Surg Tech A; 2004 Oct; 14(5):261-5. PubMed ID: 15630939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus.
    Nijhawan PK; Wang KK
    Gastrointest Endosc; 2000 Sep; 52(3):328-32. PubMed ID: 10968845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
    Pech O; Ell C
    Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities.
    Peters FP; Krishnadath KK; Rygiel AM; Curvers WL; Rosmolen WD; Fockens P; Ten Kate FJ; van Baal JW; Bergman JJ
    Am J Gastroenterol; 2007 Sep; 102(9):1853-61. PubMed ID: 17509033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia.
    Terheggen G; Horn EM; Vieth M; Gabbert H; Enderle M; Neugebauer A; Schumacher B; Neuhaus H
    Gut; 2017 May; 66(5):783-793. PubMed ID: 26801885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection for Endoscopic Therapy of Barrett's Esophagus-related Neoplasia.
    Kothari S; Kaul V
    Gastroenterol Clin North Am; 2015 Jun; 44(2):317-35. PubMed ID: 26021197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence.
    Polkowski W; van Lanschot JJ; Ten Kate FJ; Baak JP; Tytgat GN; Obertop H; Voorn WJ; Offerhaus GJ
    Surg Oncol; 1995 Jun; 4(3):163-71. PubMed ID: 7582189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.